While somatic POT1 mutations are most prevalent in angiosarcoma [13], monoallelic POT1 germline mutations are associated with a wide range of cancers, including familial melanoma, chronic lymphocytic leukemia, angiosarcoma and glioma [12,14]. This evidence concerns the gene POT1 and angiosarcoma.